The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice

• YAMAZAKI Takanori

  Department of Internal Medicine and Cardiology, Osaka City University Medical School

• YAMASHITA Naoto

  Department of Pharmacology, Osaka City University Medical School

• IZUMI Yasukatsu

  Department of Internal Medicine and Cardiology, Osaka City University Medical School

• NAKAMURA Yasuhiro

  Department of Internal Medicine and Cardiology, Osaka City University Medical School

• SHIOTA Masayuki

  Department of Pharmacology, Osaka City University Medical School

• HANATANI Akihisa

  Department of Internal Medicine and Cardiology, Osaka City University Medical School

• SHIMADA Kenei

  Department of Internal Medicine and Cardiology, Osaka City University Medical School

• MURO Takashi

  Department of Internal Medicine and Cardiology, Osaka City University Medical School

• IWAO Hiroshi

  Department of Pharmacology, Osaka City University Medical School

• YOSHIYAMA Minoru

  Department of Internal Medicine and Cardiology, Osaka City University Medical School

Journal

• Hypertens Res

  Hypertens Res 35 (1), 34-40, 2012-01-01

Keywords

• angiotensin II
• cardiac hypertrophy
• fibrosis
• gene expression
• pirfenidone

Details

• CRID: 1571980075701826816
• NII Article ID: 10030642721
• NII Book ID: AA10847079
• ISSN: 09169636
• Web Site: https://search.jamas.or.jp/link/ui/2013045956
• Text Lang: en
• Data Source:
  • CiNii Articles